Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
The end of the Humira era
EP Vantage
Mon, 01/30/23 - 10:46 am
AbbVie
Humira
patents
biosimilars
Merck
Keytruda
AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.
Motley Fool
Sun, 01/22/23 - 01:01 pm
AbbVie
Humira
biosimilars
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Wed, 01/18/23 - 11:00 pm
Amgen
Humira
biosimilars
adalimumab
Amjevita
Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM
BioSpace
Tue, 01/10/23 - 06:43 pm
Amgen
JPMHC 2023
M&A
biosimilars
Coherus pays out $32M for exclusive US commercialization rights to Eylea biosimilar
Endpoints
Tue, 01/10/23 - 06:40 pm
Coherus Biosciences
biosimilars
ophthalmology
Eylea
Regeneron
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
Drug Channels
Tue, 01/10/23 - 10:44 am
PBMs
Caremark
CVS Health
Express Scripts
Cigna
OptumRx
United Health
formularies
insulin
biosimilars
Humira
Could This Drug News Give a Lift to Eli Lilly Stock?
Motley Fool
Mon, 01/2/23 - 06:27 pm
Eli Lilly
Rezvoglar
diabetes
Sanofi
Lantus
biosimilars
long-acting insulin
Biosimilars hit a turning point as they expand outside oncology
Clinical Trials Arena
Fri, 12/9/22 - 10:31 am
biosimilars
oncology
immunology
gastroenterology
ophthalmology
Respiratory
dermatology
metabolic disorders
musculoskeletal disorders
Uptake of biosimilars on the rise in the US, but number of marketed products lags other countries
RAPS.org
Mon, 12/5/22 - 10:51 pm
biosimilars
A Supreme Court chill across biosimilar 'skinny' labels could halt billions in Medicare savings
Endpoints
Tue, 11/29/22 - 08:26 pm
Medicare
skinny labels
biosimilars
Supreme Court
Lilly wins FDA approval for second interchangeable insulin biosimilar
Endpoints
Thu, 11/17/22 - 11:27 pm
Eli Lilly
FDA
insulin
diabetes
biosimilars
Optum to add biosimilars to formulary to tackle the massive cost of Humira
Fierce Healthcare
Wed, 11/16/22 - 11:16 pm
OptumRx
AbbVie
Humira
biosimilars
Key to biosimilar competition will come from interchangeability, FDA officials say
Endpoints
Tue, 11/8/22 - 10:52 am
FDA
biosimilars
interchangeability
AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now
Endpoints
Sun, 10/30/22 - 04:22 pm
AbbVie
Humira
patents
biosimilars
earnings
patent cliff
Regeneron, Bayer's Eylea nabs six months of pediatric exclusivity as competition waits to enter the market
Endpoints
Mon, 10/24/22 - 11:10 pm
Regeneron
Bayer
Eylea
pediatric exclusivity
biosimilars
What Pharma Companies Can Expect From the Influx of Humira Biosimilars
Drug Channels
Fri, 10/14/22 - 10:15 am
AbbVie
Humira
biosimilars
Amgen
Amjevita
Amgen study: Biosimilars saved the healthcare system $21B
Medical Marketing and Media
Wed, 10/12/22 - 11:38 pm
Amgen
biosimilars
US govt addressing Medicare payments for biosimilars
Pharma Letter
Tue, 10/4/22 - 10:35 am
HHS
Medicare
biosimilars
Medicare Part B
Inflation Reduction Act
CMS
Generics, biosimilars saved the healthcare system $373B in 2021
Medical Marketing and Media
Sun, 10/2/22 - 07:43 pm
generics
biosimilars
Where Will AbbVie Be in 3 Years?
Motley Fool
Fri, 09/30/22 - 10:50 am
AbbVie
Humira
biosimilars
Rinvoq
Skyrizi
Vraylar
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »